top of page
Our mission is to accelerate the translation of world-class research discoveries to optimal care for breast cancer patients
TransBCR supports three complimentary research platforms
Clinical Trials
Clinical trials of targeted therapies in breast cancer, including early Phase 0, I and II studies, encompassing breast cancer prevention, neo-adjuvant therapy, and treatment of advanced disease.
​
These studies will enable innovative Phase III trials that require companion biomarker evaluation.
​
Breast Biomarker Program
The Breast Biomarker Program coordinates the prospective collection and testing of tumour and normal breast tissue samples for different research projects.
​
These samples may be evaluated for molecular markers to guide patient selection for suitable clinical trials and therapy.
DCISion
Ductal Carcinoma In Situ (DCIS) is a type of pre-invasive breast cancer.
This project aims to build a bank of highly annotated DCIS tissue samples for biomarker research.
bottom of page